Biostem Technologies Inc
OTC:BSEM

Watchlist Manager
Biostem Technologies Inc Logo
Biostem Technologies Inc
OTC:BSEM
Watchlist
Price: 13.28 USD -1.99%
Market Cap: 217m USD
Have any thoughts about
Biostem Technologies Inc?
Write Note

Biostem Technologies Inc
Other Non-Cash Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biostem Technologies Inc
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
Biostem Technologies Inc
OTC:BSEM
Other Non-Cash Items
$7.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Other Non-Cash Items
$3.5B
CAGR 3-Years
37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Other Non-Cash Items
$14.3B
CAGR 3-Years
6%
CAGR 5-Years
90%
CAGR 10-Years
80%
Pfizer Inc
NYSE:PFE
Other Non-Cash Items
$6.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
35%
Merck & Co Inc
NYSE:MRK
Other Non-Cash Items
$5.1B
CAGR 3-Years
-12%
CAGR 5-Years
12%
CAGR 10-Years
27%
Eli Lilly and Co
NYSE:LLY
Other Non-Cash Items
$4.5B
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
26%
No Stocks Found

Biostem Technologies Inc
Glance View

Market Cap
217m USD
Industry
Pharmaceuticals

BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. The company is headquartered in Pompano Beach, Florida. The company went IPO on 2001-07-11. The firm is focused on harnessing elements of perinatal tissue and the body’s innate biology to repair or reverse damage caused by a range of degenerative diseases. Its approach, called Local MicroEnvironment Activation (LMA) platform uses combinations of small molecules, cytokines, and growth factors to activate the microenvironment within the body to create communication for repair in the tissue. Its products include RHEO, OROPRO, AEON, VENDAJE, VENDAJE AC, VENDAJE OPTIC, PROVISCUS, NEOFYL and ONIX. Its RHEO is a cushioning agent for homologous supplementation, which is derived from human amniotic tissue. Its OROPRO is derived from human umbilical cord and is a Wharton's jelly tissue allograft. Its VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. The VENDAJE AC is a structural tissue allograft composed of the amnion and chorion layer of the placental membrane.

BSEM Intrinsic Value
18.02 USD
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Biostem Technologies Inc's Other Non-Cash Items?
Other Non-Cash Items
7.2m USD

Based on the financial report for Dec 31, 2023, Biostem Technologies Inc's Other Non-Cash Items amounts to 7.2m USD.

Back to Top